These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 29523451)

  • 1. Prevalence and genetic characteristics of 4CMenB and rLP2086 vaccine candidates among Neisseria meningitidis serogroup B strains, China.
    Zhu B; Shi F; Zhang A; Sun X; Xu Z; Xu L; Gao Y; Lv J; Shao Z
    Vaccine; 2018 Apr; 36(15):1983-1989. PubMed ID: 29523451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular characteristics of serogroup B
    Zhu BQ; Gao WY; Xu L; Gao Y; Shao ZJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Feb; 53(2):153-158. PubMed ID: 30744288
    [No Abstract]   [Full Text] [Related]  

  • 3. Diversity of Greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine.
    Tzanakaki G; Hong E; Kesanopoulos K; Xirogianni A; Bambini S; Orlandi L; Comanducci M; Muzzi A; Taha MK
    BMC Microbiol; 2014 Apr; 14():111. PubMed ID: 24779381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variability of Polish serogroup B meningococci (2010-2016) including the 4CMenB vaccine component genes.
    Waśko I; Gołębiewska A; Kiedrowska M; Ronkiewicz P; Wróbel-Pawelczyk I; Kuch A; Hong E; Skoczyńska A
    Vaccine; 2020 Feb; 38(8):1943-1952. PubMed ID: 31980191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B
    Mulhall RM; Bennett D; Cunney R; Borrow R; Lucidarme J; Findlow J; Jolley KA; Bray J; Maiden MCJ; Moschioni M; Serino L; Stella M; Medini D
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30135218
    [No Abstract]   [Full Text] [Related]  

  • 6. Prediction by genetic MATS of 4CMenB vaccine strain coverage of invasive meningococcal serogroup B isolates circulating in Taiwan between 2003 and 2020.
    Muzzi A; Lu M-C; Mori E; Biolchi A; Fu T; Serino L
    mSphere; 2024 Jun; 9(6):e0022024. PubMed ID: 38752729
    [No Abstract]   [Full Text] [Related]  

  • 7. Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB).
    Bettinger JA; Scheifele DW; Halperin SA; Vaudry W; Findlow J; Borrow R; Medini D; Tsang R;
    Vaccine; 2013 Dec; 32(1):124-30. PubMed ID: 23588089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of invasive serogroup B Neisseria meningitidis isolates from Spain during 2015-2018: Evolution of the vaccine antigen factor H binding protein (FHbp).
    Abad R; García-Amil C; Navarro C; Martín E; Martín-Díaz A; Vázquez JA
    J Infect; 2021 Apr; 82(4):37-44. PubMed ID: 33610688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines against Neisseria meningitidis serogroup B strains - What does genomics reveal on the Portuguese strain's coverage.
    Bettencourt C; Nogueira P; Paulo Gomes J; João Simões M
    Vaccine; 2022 Aug; 40(33):4772-4779. PubMed ID: 35778280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High predicted strain coverage by the multicomponent meningococcal serogroup B vaccine (4CMenB) in Poland.
    Waśko I; Hong E; De Paola R; Stella M; Moschioni M; Taha MK; Skoczyńska A
    Vaccine; 2016 Jan; 34(4):510-515. PubMed ID: 26686998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of factor H Binding Protein sub-variants among Neisseria meningitidis in China.
    Shi F; Zhang A; Zhu B; Gao Y; Xu L; Li Y; Yin Z; Li J; Xie N; Shao Z
    Vaccine; 2017 Apr; 35(18):2343-2350. PubMed ID: 28351732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Culture-Confirmed Invasive Meningococcal Disease in Canada, 2010 to 2014: Characterization of Serogroup B
    Tsang RSW; Law DKS; De Paola R; Giuliani M; Stella M; Zhou J; Deng S; Boccadifuoco G; Giuliani MM; Serino L
    mSphere; 2020 Mar; 5(2):. PubMed ID: 32132156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of invasive Neisseria meningitidis strains from Québec, Canada, during a period of increased serogroup B disease, 2009-2013: phenotyping and genotyping with special emphasis on the non-carbohydrate protein vaccine targets.
    Law DK; Lefebvre B; Gilca R; Deng S; Zhou J; De Wals P; Tsang RS
    BMC Microbiol; 2015 Jul; 15():143. PubMed ID: 26204985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic surveillance of Neisseria meningitidis serogroup B invasive strains: Diversity of vaccine antigen types, Brazil, 2016-2018.
    de Lemos APS; Sacchi CT; Gonçalves CR; Camargo CH; Andrade AL
    PLoS One; 2020; 15(12):e0243375. PubMed ID: 33347452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage.
    Frosi G; Biolchi A; Lo Sapio M; Rigat F; Gilchrist S; Lucidarme J; Findlow J; Borrow R; Pizza M; Giuliani MM; Medini D
    Vaccine; 2013 Oct; 31(43):4968-74. PubMed ID: 23954380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility of Meningococcal Strains Responsible for Two Serogroup B Outbreaks on U.S. University Campuses to Serum Bactericidal Activity Elicited by the MenB-4C Vaccine.
    Rossi R; Beernink PT; Giuntini S; Granoff DM
    Clin Vaccine Immunol; 2015 Dec; 22(12):1227-34. PubMed ID: 26424832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine.
    Marjuki H; Topaz N; Joseph SJ; Gernert KM; Kersh EN; ; Wang X
    mBio; 2019 Sep; 10(5):. PubMed ID: 31506309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic characteristics of Neisseria meningitidis serogroup B strains carried by adolescents living in Milan, Italy: implications for vaccine efficacy.
    Esposito S; Zampiero A; Terranova L; Montinaro V; Scala A; Ansuini V; Principi N
    Hum Vaccin Immunother; 2013 Nov; 9(11):2296-303. PubMed ID: 23880917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of serotyping antigens, clonal analysis and genetic characterization of the 4CMenB vaccine antigen genes in invasive Neisseria meningitidis from Western Canada, 2009 to 2013.
    Law DKS; Zhou J; Deng S; Hoang L; Tyrrell G; Horsman G; Wylie J; Tsang RSW
    J Med Microbiol; 2014 Nov; 63(Pt 11):1490-1499. PubMed ID: 25165123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology of Neisseria meningitidis serogroup B in Brazil.
    de Filippis I; de Lemos AP; Hostetler JB; Wollenberg K; Sacchi CT; Dunning Hotopp JC; Harrison LH; Bash MC; Prevots DR
    PLoS One; 2012; 7(3):e33016. PubMed ID: 22431994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.